Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 245

  • Showing results for a modified search because your search retrieved no results.
1.

A role for APP in Wnt signalling links synapse loss with β-amyloid production.

Elliott C, Rojo AI, Ribe E, Broadstock M, Xia W, Morin P, Semenov M, Baillie G, Cuadrado A, Al-Shawi R, Ballard CG, Simons P, Killick R.

Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.

PMID:
30232325
2.

Therapies for cardiac light chain amyloidosis: An update.

Aimo A, Buda G, Fontana M, Barison A, Vergaro G, Emdin M, Merlini G.

Int J Cardiol. 2018 Nov 15;271:152-160. doi: 10.1016/j.ijcard.2018.05.018.

PMID:
30223349
3.

Mortalities, amyloidosis and other diseases in free-living red squirrels (Sciurus vulgaris) on Jersey, Channel Islands.

Blackett TA, Simpson VR, Haugland S, Everest DJ, Muir CF, Smith KC, Mill AC.

Vet Rec. 2018 Sep 4. pii: vetrec-2017-104779. doi: 10.1136/vr.104779. [Epub ahead of print]

PMID:
30181130
4.

Cryopyrin-Associated Periodic Fever Syndrome and the Nervous System.

Keddie S, Parker T, Lachmann HJ, Ginsberg L.

Curr Treat Options Neurol. 2018 Sep 3;20(10):43. doi: 10.1007/s11940-018-0526-1. Review.

5.

A small population, randomised, placebo-controlled trial to determine the efficacy of anakinra in the treatment of pustular psoriasis: study protocol for the APRICOT trial.

Cornelius V, Wilson R, Cro S, Barker J, Burden D, Griffiths CEM, Lachmann H, McAteer H, Reynolds N, Pink A, Warren RB, Capon F, Smith C.

Trials. 2018 Aug 29;19(1):465. doi: 10.1186/s13063-018-2841-y.

6.

Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p.

Wong SW, Hegenbart U, Palladini G, Shah GL, Landau HJ, Warner M, Toskic D, Jaccard A, Hansen T, Bladé J, Cibeira MT, Kastritis E, Dispenzieri A, Wechalekar A, Varga C, Schönland SO, Comenzo RL.

Clin Lymphoma Myeloma Leuk. 2018 Jul 25. pii: S2152-2650(18)30567-6. doi: 10.1016/j.clml.2018.07.292. [Epub ahead of print]

7.

Phenotypic profile of Ile68Leu transthyretin amyloidosis: an underdiagnosed cause of heart failure.

Gagliardi C, Perfetto F, Lorenzini M, Ferlini A, Salvi F, Milandri A, Quarta CC, Taborchi G, Bartolini S, Frusconi S, Martone R, Cinelli MM, Foffi S, Reggiani MLB, Fabbri G, Cataldo P, Cappelli F, Rapezzi C.

Eur J Heart Fail. 2018 Aug 2. doi: 10.1002/ejhf.1285. [Epub ahead of print]

PMID:
30070416
8.

Plasminogen activation triggers transthyretin amyloidogenesis in vitro.

Mangione PP, Verona G, Corazza A, Marcoux J, Canetti D, Giorgetti S, Raimondi S, Stoppini M, Esposito M, Relini A, Canale C, Valli M, Marchese L, Faravelli G, Obici L, Hawkins PN, Taylor GW, Gillmore JD, Pepys MB, Bellotti V.

J Biol Chem. 2018 Sep 14;293(37):14192-14199. doi: 10.1074/jbc.RA118.003990. Epub 2018 Jul 17.

9.

Simultaneous Clinical Presentation of Renal Cell Carcinoma and Immunoglobulin Light Chain Amyloidosis.

Prasad B, Tangedal K, Chibbar R, McIsaac M.

Cureus. 2018 May 6;10(5):e2585. doi: 10.7759/cureus.2585.

10.

Myocardial Edema and Prognosis in Amyloidosis.

Kotecha T, Martinez-Naharro A, Treibel TA, Francis R, Nordin S, Abdel-Gadir A, Knight DS, Zumbo G, Rosmini S, Maestrini V, Bulluck H, Rakhit RD, Wechalekar AD, Gilbertson J, Sheppard MN, Kellman P, Gillmore JD, Moon JC, Hawkins PN, Fontana M.

J Am Coll Cardiol. 2018 Jun 26;71(25):2919-2931. doi: 10.1016/j.jacc.2018.03.536.

PMID:
29929616
11.

Treatment of IgM-associated immunoglobulin light-chain amyloidosis with rituximab-bendamustine.

Manwani R, Sachchithanantham S, Mahmood S, Foard D, Sharpley F, Rezk T, Lane T, Quarta C, Fontana M, Lachmann HJ, Gillmore JD, Whelan C, Hawkins PN, Wechalekar AD.

Blood. 2018 Aug 16;132(7):761-764. doi: 10.1182/blood-2018-04-846493. Epub 2018 Jun 20. No abstract available.

PMID:
29925500
12.

Periodic fever syndromes.

Lachmann HJ.

Best Pract Res Clin Rheumatol. 2017 Aug;31(4):596-609. doi: 10.1016/j.berh.2017.12.001. Epub 2018 Jan 11. Review.

PMID:
29773275
13.

Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes.

De Benedetti F, Gattorno M, Anton J, Ben-Chetrit E, Frenkel J, Hoffman HM, Koné-Paut I, Lachmann HJ, Ozen S, Simon A, Zeft A, Calvo Penades I, Moutschen M, Quartier P, Kasapcopur O, Shcherbina A, Hofer M, Hashkes PJ, Van der Hilst J, Hara R, Bujan-Rivas S, Constantin T, Gul A, Livneh A, Brogan P, Cattalini M, Obici L, Lheritier K, Speziale A, Junge G.

N Engl J Med. 2018 May 17;378(20):1908-1919. doi: 10.1056/NEJMoa1706314.

PMID:
29768139
14.

Successful treatment of systemic AA amyloidosis associated with underlying Hodgkin lymphoma.

Manwani R, Wrench D, Wechalekar A, Lachmann H.

Br J Haematol. 2018 Sep;182(5):619. doi: 10.1111/bjh.15269. Epub 2018 May 16. No abstract available.

PMID:
29767440
15.

Cardiac amyloidosis.

Martinez-Naharro A, Hawkins PN, Fontana M.

Clin Med (Lond). 2018 Apr 1;18(Suppl 2):s30-s35. doi: 10.7861/clinmedicine.18-2-s30.

PMID:
29700090
16.

Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles.

Knight DS, Zumbo G, Barcella W, Steeden JA, Muthurangu V, Martinez-Naharro A, Treibel TA, Abdel-Gadir A, Bulluck H, Kotecha T, Francis R, Rezk T, Quarta CC, Whelan CJ, Lachmann HJ, Wechalekar AD, Gillmore JD, Moon JC, Hawkins PN, Fontana M.

JACC Cardiovasc Imaging. 2018 Apr 13. pii: S1936-878X(18)30213-4. doi: 10.1016/j.jcmg.2018.02.016. [Epub ahead of print]

PMID:
29680336
17.

Extracardiac 18F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds.

Wagner T, Page J, Burniston M, Skillen A, Ross JC, Manwani R, McCool D, Hawkins PN, Wechalekar AD.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1129-1138. doi: 10.1007/s00259-018-3995-2. Epub 2018 Apr 12.

18.

[18F]Florbetaben PET-CT confirms AL amyloidosis in a patient with Waldenström's Macroglobulinemia.

Fox TA, Lunn M, Wechalekar A, Bomanji J, Wan S, D'Sa S.

Haematologica. 2018 Jul;103(7):e322-e324. doi: 10.3324/haematol.2017.184515. Epub 2018 Apr 12. No abstract available.

19.

Myocardial native T1 and extracellular volume with healthy ageing and gender.

Rosmini S, Bulluck H, Captur G, Treibel TA, Abdel-Gadir A, Bhuva AN, Culotta V, Merghani A, Fontana M, Maestrini V, Herrey AS, Chow K, Thompson RB, Piechnik SK, Kellman P, Manisty C, Moon JC.

Eur Heart J Cardiovasc Imaging. 2018 Jun 1;19(6):615-621. doi: 10.1093/ehjci/jey034.

20.

New workflow for classification of genetic variants' pathogenicity applied to hereditary recurrent fevers by the International Study Group for Systemic Autoinflammatory Diseases (INSAID).

Van Gijn ME, Ceccherini I, Shinar Y, Carbo EC, Slofstra M, Arostegui JI, Sarrabay G, Rowczenio D, Omoyımnı E, Balci-Peynircioglu B, Hoffman HM, Milhavet F, Swertz MA, Touitou I.

J Med Genet. 2018 Aug;55(8):530-537. doi: 10.1136/jmedgenet-2017-105216. Epub 2018 Mar 29.

PMID:
29599418

Supplemental Content

Loading ...
Support Center